A Phase 3, open-label study to evaluate NS-32 in subjects with iron deficiency anemia associated with postpartum hemorrhage
Phase 3
Completed
- Conditions
- Iron Deficiency Anemia
- Registration Number
- JPRN-jRCT2080224805
- Lead Sponsor
- ippon Shinyaku Co., Ltd.
- Brief Summary
There was a significant difference in the maximum change in hemoglobin concentration from baseline for the primary endpoint. All TEAEs were mild except for the moderate jaundice neonatal reported in 1 neonate and no serious related SAEs were reported.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Female
- Target Recruitment
- 21
Inclusion Criteria
Patients diagnosed with IDA associated with postpartum heamorrhage
Exclusion Criteria
Patients with anemia due to causes other than iron deficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method